Chien-Kuo Tai

1.0k total citations
23 papers, 801 citations indexed

About

Chien-Kuo Tai is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Chien-Kuo Tai has authored 23 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Chien-Kuo Tai's work include Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (6 papers) and Epigenetics and DNA Methylation (5 papers). Chien-Kuo Tai is often cited by papers focused on Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (6 papers) and Epigenetics and DNA Methylation (5 papers). Chien-Kuo Tai collaborates with scholars based in Taiwan, United States and Switzerland. Chien-Kuo Tai's co-authors include Noriyuki Kasahara, Christopher R. Logg, W. French Anderson, Thomas C. Chen, Tai‐Kuang Chao, Michael W.Y. Chan, Kenneth P. Nephew, Pearlly S. Yan, Paula M. Cannon and Yufen Li and has published in prestigious journals such as Cancer Research, Journal of Virology and Scientific Reports.

In The Last Decade

Chien-Kuo Tai

22 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien-Kuo Tai Taiwan 13 583 327 165 125 62 23 801
Susana Seixas Portugal 19 405 0.7× 211 0.6× 188 1.1× 233 1.9× 84 1.4× 46 976
Haruki Kaku Japan 16 447 0.8× 189 0.6× 188 1.1× 78 0.6× 32 0.5× 35 757
Ida Casciano Italy 20 658 1.1× 133 0.4× 262 1.6× 272 2.2× 87 1.4× 47 1.1k
Bolette Bjerregaard Denmark 14 412 0.7× 130 0.4× 188 1.1× 59 0.5× 30 0.5× 17 682
Emmanuel Payen France 23 1.0k 1.8× 795 2.4× 109 0.7× 61 0.5× 27 0.4× 46 1.6k
Katherine Rhodes United States 15 549 0.9× 225 0.7× 79 0.5× 148 1.2× 41 0.7× 19 838
Nikki Levin United States 13 403 0.7× 173 0.5× 267 1.6× 96 0.8× 130 2.1× 34 811
Catherine Degnin United States 18 760 1.3× 170 0.5× 228 1.4× 71 0.6× 140 2.3× 52 1.1k
Wenjuan Zhang China 17 584 1.0× 249 0.8× 92 0.6× 81 0.6× 39 0.6× 41 988

Countries citing papers authored by Chien-Kuo Tai

Since Specialization
Citations

This map shows the geographic impact of Chien-Kuo Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien-Kuo Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien-Kuo Tai more than expected).

Fields of papers citing papers by Chien-Kuo Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien-Kuo Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien-Kuo Tai. The network helps show where Chien-Kuo Tai may publish in the future.

Co-authorship network of co-authors of Chien-Kuo Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Chien-Kuo Tai. A scholar is included among the top collaborators of Chien-Kuo Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien-Kuo Tai. Chien-Kuo Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Yung‐Chih, et al.. (2025). Etoposide-loaded lipopolymer nanoparticles promote Smac minetic activity against inhibitor of apoptosis protein for glioblastoma treatment. Biomaterials Advances. 170. 214185–214185. 1 indexed citations
2.
Liao, Xiao-Hui, Sherry Y. Wu, Yufen Li, et al.. (2025). Methylation-Mediated Silencing of miR-124-3 Regulates LRRC1 Expression and Promotes Oral Cancer Progression. Cancers. 17(7). 1136–1136. 1 indexed citations
3.
Chen, Ying‐Ju, et al.. (2024). Epigenetic downregulation of the proapoptotic gene HOXA5 in oral squamous cell carcinoma. Molecular Medicine Reports. 31(3).
4.
5.
Wang, Yi‐Cheng, Po‐Ming Chen, Chien-Kuo Tai, et al.. (2021). MTHFR Knockdown Assists Cell Defense against Folate Depletion Induced Chromosome Segregation and Uracil Misincorporation in DNA. International Journal of Molecular Sciences. 22(17). 9392–9392. 9 indexed citations
6.
Collins, Sara, Deching Chang, Shu‐Fen Wu, et al.. (2020). Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. International Journal of Molecular Sciences. 21(4). 1433–1433. 9 indexed citations
7.
Wu, Musheng, Chiung‐Yao Fang, Chien-Kuo Tai, et al.. (2018). Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector. Scientific Reports. 8(1). 2213–2213. 36 indexed citations
8.
Chen, Ying‐Ju, et al.. (2016). Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2. Oncology Letters. 12(3). 2107–2114. 7 indexed citations
9.
Tu, Dom‐Gene, et al.. (2016). Promotion of metastasis of thyroid cancer cells via NRP-2-mediated induction. Oncology Letters. 12(5). 4224–4230. 17 indexed citations
10.
Huang, Rui, Pearlly S. Yan, Wei‐Ting Chao, et al.. (2015). Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients. Clinical Epigenetics. 7(1). 1–1. 165 indexed citations
11.
Li, Yufen, Yi‐Chen Chen, Ying‐Ju Chen, et al.. (2015). DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics. 10(3). 229–236. 54 indexed citations
12.
Chou, Jian‐Liang, et al.. (2014). Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma. Journal of Translational Medicine. 12(1). 237–237. 22 indexed citations
13.
Lin, Ming‐Shian, et al.. (2013). Primary erector spinae pyomyositis with an epidural abscess. The Spine Journal. 13(9). 1156–1157. 2 indexed citations
14.
Ho, Ching‐Liang, Chien-Kuo Tai, Shuting Liu, et al.. (2010). Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations. The International Journal of Biochemistry & Cell Biology. 42(6). 902–910. 6 indexed citations
15.
Chou, Jian‐Liang, Her‐Young Su, Lin‐Yu Chen, et al.. (2010). Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Laboratory Investigation. 90(3). 414–425. 99 indexed citations
16.
Li, Yufen, et al.. (2009). NAD(P)H: Quinone oxidoreductase 1, glutathione S-transferase M1, environmental tobacco smoke exposure, and childhood asthma. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 678(1). 53–58. 17 indexed citations
17.
Tai, Chien-Kuo. (2007). Replication-competent retrovirus vectors for cancer gene therapy. Frontiers in bioscience. 13(13). 3083–3083. 54 indexed citations
18.
Tai, Chien-Kuo, Christopher R. Logg, Jinha Park, et al.. (2003). Antibody-Mediated Targeting of Replication-Competent Retroviral Vectors. Human Gene Therapy. 14(8). 789–802. 37 indexed citations
19.
Tai, Chien-Kuo, et al.. (2003). Highly Efficient and Tumor-Restricted Gene Transfer to Malignant Gliomas by Replication-Competent Retroviral Vectors. Human Gene Therapy. 14(2). 117–127. 70 indexed citations
20.
Logg, Christopher R., et al.. (2001). A Uniquely Stable Replication-Competent Retrovirus Vector Achieves Efficient Gene Delivery in Vitro and in Solid Tumors. Human Gene Therapy. 12(8). 921–932. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026